छोड़कर सामग्री पर जाएँ

Cipla may extend losses on USFDA warning, HSBC cuts target price

  • द्वारा
  • Latest News

According to analysts at HSBC, the USFDA#39;s warning letter to Cipla hints at a lengthy resolution timeline and incremental costs

Read More

​ According to analysts at HSBC, the USFDA#39;s warning letter to Cipla hints at a lengthy resolution timeline and incremental costs According to analysts at HSBC, the USFDA#39;s warning letter to Cipla hints at a lengthy resolution timeline and incremental costs  Moneycontrol Latest News Read More  

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी